Literature DB >> 7423534

Absorption and tissue distribution of curcumin in rats.

V Ravindranath, N Chandrasekhara.   

Abstract

After oral administration of 400 mg curcumin to rats, about 60% of the dose was absorbed. No curcumin was detectable in urine. The urinary excretion of conjugated glucuronides and sulfates significantly increased. No curcumin was present in heart blood. Only traces (less than 5 microgram/ml) in portal blood and negligible quantities in liver and kidney (< 20 micrograms/tissue) were observed from 15 min upto 24 h after administration of curcumin. At the end of 24 h the concentration of curcumin remaining in the lower part of the gut namely caecum and large intestine amounted to 38% of the quantity administered.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7423534     DOI: 10.1016/0300-483x(80)90122-5

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  84 in total

Review 1.  Colorectal cancer: chemopreventive role of curcumin and resveratrol.

Authors:  Vaishali B Patel; Sabeena Misra; Bhaumik B Patel; Adhip P N Majumdar
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

2.  Effect on pro-inflammatory and antioxidant genes and bioavailable distribution of whole turmeric vs curcumin: Similar root but different effects.

Authors:  Robert C G Martin; Harini S Aiyer; Daniel Malik; Yan Li
Journal:  Food Chem Toxicol       Date:  2011-11-04       Impact factor: 6.023

3.  Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection.

Authors:  Neha Sharma; Sheetal Sharma; Bimla Nehru
Journal:  Inflammopharmacology       Date:  2017-04-13       Impact factor: 4.473

4.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

Review 5.  Therapeutic potential of curcumin in digestive diseases.

Authors:  Pietro Dulbecco; Vincenzo Savarino
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

6.  Effects of hexahydrocurcumin in combination with 5-fluorouracil on dimethylhydrazine-induced colon cancer in rats.

Authors:  Khanitta Srimuangwong; Chainarong Tocharus; Jiraporn Tocharus; Apichart Suksamrarn; Pornphorm Yoysungnoen Chintana
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 7.  Curcumin for maintenance of remission in ulcerative colitis.

Authors:  Sushil Kumar; Vineet Ahuja; Mari Jeeva Sankar; Atul Kumar; Alan C Moss
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

Review 8.  Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.

Authors:  Avijit Sarkar; Ronita De; Asish K Mukhopadhyay
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

9.  Lung tumor promotion by curcumin.

Authors:  Stephanie T Dance-Barnes; Nancy D Kock; Joseph E Moore; Elaine Y Lin; Libyadda J Mosley; Ralph B D'Agostino; Thomas P McCoy; Alan J Townsend; Mark Steven Miller
Journal:  Carcinogenesis       Date:  2009-04-09       Impact factor: 4.944

10.  A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95CG (Biocurcumax), A Novel Bioenhanced Preparation of Curcumin.

Authors:  B Antony; B Merina; V S Iyer; N Judy; K Lennertz; S Joyal
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.